Latest Breaking News On - Irmatrelvir the antiviral medicine and ritonavir to maintain blood level of nirmatrelvir for efficacy - Page 1 : comparemela.com

The Health Sciences Authority (HSA), in consultation with its Medicines Advisory Committee, granted interim authorisation under the Pandemic Special Access Route (PSAR) for Pfizer’s Paxlovid, a combination of two medicines, nirmatrelvir (the antiviral medicine) and ritonavir (to maintain the blood level of nirmatrelvir for antiviral efficacy).

Medicines advisory committeeHealth sciences authorityPandemic special access routeThe health sciences authority hsaN consultation with its medicines advisory committeeRanted interim authorisation under the pandemic special access route psar for pfizers paxlovidA combination of two medicinesIrmatrelvir the antiviral medicine and ritonavir to maintain blood level of nirmatrelvir for efficacy